Goldman Sachs’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3M | Buy |
|
|||||
|
2025
Q1 | $27M | Sell |
|
|||||
|
2024
Q4 | $33.8M | Buy |
|
|||||
|
2024
Q3 | $28.1M | Buy |
|
|||||
|
2024
Q2 | $15.8M | Buy |
|
|||||
|
2024
Q1 | $10.7M | Buy |
|
|||||
|
2023
Q4 | $6.92M | Buy |
|
|||||
|
2023
Q3 | $4.34M | Sell |
|
|||||
|
2023
Q2 | $5.75M | Sell |
|
|||||
|
2023
Q1 | $10.3M | Sell |
|
|||||
|
2022
Q4 | $11.4M | Buy |
|
|||||
|
2022
Q3 | $7.51M | Sell |
|
|||||
|
2022
Q2 | $8.89M | Sell |
|
|||||
|
2022
Q1 | $17.8M | Buy |
|
|||||
|
2021
Q4 | $7.71M | Buy |
|
|||||
|
2021
Q3 | $6.98M | Buy |
|
|||||
|
2021
Q2 | $7.74M | Buy |
|
|||||
|
2021
Q1 | $5.06M | Sell |
|
|||||
|
2020
Q4 | $8.71M | Buy |
|
|||||
|
2020
Q3 | $5.15M | Buy |
|
|||||
|
2020
Q2 | $5.68M | Sell |
|
|||||
|
2020
Q1 | $9.26M | Sell |
|
|||||
|
2019
Q4 | $16.6M | Buy |
|
|||||
|
2019
Q3 | $8.8M | Buy |
|
|||||
|
2019
Q2 | $5.61M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Buy |
|
|||||
|
2018
Q4 | $7.46M | Sell |
|
|||||
|
2018
Q3 | $15.9M | Sell |
|
|||||
|
2018
Q2 | $26.7M | Sell |
|
|||||
|
2018
Q1 | $21.4M | Buy |
|
|||||
|
2017
Q4 | $10.7M | Sell |
|
|||||
|
2017
Q3 | $12.1M | Buy |
|
|||||
|
2017
Q2 | $8.83M | Buy |
|
|||||
|
2017
Q1 | $5.59M | Sell |
|
|||||
|
2016
Q4 | $5.52M | Buy |
|
|||||
|
2016
Q3 | $5.15M | Buy |
|
|||||
|
2016
Q2 | $782K | Sell |
|
|||||
|
2016
Q1 | $818K | Buy |
|
|||||
|
2015
Q4 | $454K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.78M | Buy |
|
|||||
|
2015
Q1 | $206K | Sell |
|
|||||
|
2014
Q4 | $299K | Buy |
|
|||||
|
2014
Q3 | $136K | Buy |
|
|||||
|
2014
Q2 | $142K | Sell |
|
|||||
|
2014
Q1 | $262K | Sell |
|
|||||
|
2013
Q4 | $812K | Buy |
|